HAS Healthcare Advanced Synthesis SA acquires Cerbios-Pharma SA to create leading international Group in the CDMO sector, backed by 65 Equity Partners

The transaction remains subject to regulatory and tax clearances. BIASCA, Switzerland, March 31, 2025 /PRNewswire/ — HAS Healthcare Advanced Synthesis SA (“HAS”), a leading international developer and producer of active pharmaceutical ingredients (APIs), high-potency active pharmaceutical ingredients (HPAPIs), and anticancer compounds, today announces the planned acquisition of Cerbios-Pharma SA (“Cerbios”), a globally recognised manufacturer of chemical […] L'articolo HAS Healthcare Advanced Synthesis SA acquires Cerbios-Pharma SA to create leading international Group in the CDMO sector, backed by 65 Equity Partners proviene da La Ragione.

CONTINUA A LEGGERE